In intermediate-risk acute PE, tenecteplase plus heparin reduced hemodynamic decompensation but increased stroke.
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- 2014
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Female (MeSH)
- Fibrinolytic Agents (MeSH)
- Heparin (MeSH)
- Humans (MeSH)
- Male (MeSH)
- Pulmonary Embolism (MeSH)
- Tissue Plasminogen Activator (MeSH)
published in
- ACP journal club Journal